BOTTA, CIRINO
 Distribuzione geografica
Continente #
EU - Europa 864
NA - Nord America 821
AS - Asia 143
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.831
Nazione #
US - Stati Uniti d'America 821
GB - Regno Unito 389
IE - Irlanda 155
CN - Cina 82
IT - Italia 76
SE - Svezia 60
UA - Ucraina 55
DE - Germania 43
FR - Francia 26
VN - Vietnam 18
IN - India 15
BE - Belgio 14
FI - Finlandia 14
TR - Turchia 14
ES - Italia 11
RU - Federazione Russa 8
IM - Isola di Man 7
SG - Singapore 7
IR - Iran 3
AT - Austria 2
HK - Hong Kong 2
PL - Polonia 2
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
LT - Lituania 1
NL - Olanda 1
ZA - Sudafrica 1
Totale 1.831
Città #
Southend 365
Dublin 148
Fairfield 114
Chandler 72
Ashburn 65
Ann Arbor 63
Wilmington 54
Jacksonville 51
Seattle 47
Menlo Park 45
Woodbridge 45
Cambridge 43
Siena 40
Houston 32
Beijing 24
New York 20
Princeton 20
Dong Ket 18
Dearborn 17
Brussels 14
Fremont 14
Izmir 13
Nanjing 13
Málaga 11
Helsinki 10
Boardman 9
San Mateo 8
Douglas 7
Falls Church 7
Munich 6
Shanghai 6
Shenyang 6
Florence 5
Hebei 5
Lancaster 5
Nanchang 5
San Diego 5
Jinan 4
Singapore 4
Tianjin 4
Fuzhou 3
Hangzhou 3
Moscow 3
Mumbai 3
Phoenix 3
Bari 2
Duncan 2
Hong Kong 2
London 2
Sezze 2
Turin 2
Vienna 2
Zanjan 2
Zhengzhou 2
Alghero 1
Amsterdam 1
Andover 1
Bangalore 1
Borghetto Lodigiano 1
Buffalo 1
Campi Bisenzio 1
Canberra 1
Carraia 1
Changsha 1
Delhi 1
Dhaka 1
Edinburgh 1
Falkenstein 1
Foligno 1
Gauteng 1
Giussano 1
Henderson 1
Hounslow 1
Katowice 1
Kilburn 1
Kocaeli 1
Kunming 1
Kyiv 1
Leawood 1
Messina 1
Modena 1
Ningbo 1
Philadelphia 1
Prato 1
Saint Louis 1
Sandston 1
Taizhou 1
Warsaw 1
Yerevan 1
Totale 1.512
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 231
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 225
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 211
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 175
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 167
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 164
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 147
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 142
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 116
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 61
Totale 1.878
Categoria #
all - tutte 4.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020380 45 8 23 40 29 43 40 41 42 37 14 18
2020/2021360 18 42 7 34 25 42 8 41 34 59 15 35
2021/2022199 10 24 10 10 21 10 14 10 21 21 14 34
2022/2023249 14 25 35 34 25 46 8 18 16 16 8 4
2023/2024237 8 5 17 13 4 65 108 1 2 4 1 9
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 1.878